Back to the program

“A LONG ROAD TO RECOVERY” – A family case presentation on multi-drug resistant tuberculosis infection

Hazel LUCI

This case examines a household in the launching stage of the family life cycle, a period when children transition toward independence. Ordinarily, this stage requires parents to redefine roles and cope with the “empty nest” experience. However, the father’s diagnosis of multidrug-resistant tuberculosis (MDR-TB) complicates this transition, creating overlapping stressors for both patient and family. The impact of illness is profound, producing distress, isolation, and diminished self-worth in the patient, while the family faces financial burdens and anxiety. Misconceptions about TB were corrected through the Health Belief Model, improving self-efficacy and adherence. Within the family illness trajectory (Stage III), the physician coordinates therapy and education, underscoring the need for holistic, family-centered care.The method used is a holistic, family-centered case study approach, combining SCREEM, ecomap, family life cycle analysis, illness trajectory, and the Health Belief Model. This multi-framework method allows physicians to assess medical, psychological, social, cultural, and economic dimensions, ensuring comprehensive care planning and family adaptation.Can be seen in how people approach challenges, express themselves, or invent solutions.Illness during the launching stage of the family life cycle magnifies vulnerabilities but also reveals resilience. With coordinated medical care, family support, and community resources, both patient and family can adapt, sustain hope, and navigate the challenges of TB while maintaining functional family roles.Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis, primarily affecting the lungs. It is both curable and preventable, yet remains a major global health challenge. Transmission occurs through airborne particles released when an infected person coughs, sneezes, or talks. Individuals infected with TB bacteria face a 5–10% lifetime risk of developing active disease. The 6-month BPaLM regimen is currently the preferred option for most MDR/RR-TB patients, offering improved outcomes compared to older, longer treatmentsMDR-TB is not solely a biomedical condition but a multifaceted challenge encompassing medical, psychological, social, and economic dimensions. Addressing this disease requires coordinated action among patients, families, healthcare providers, and policymakers. A holistic, family-centered strategy is imperative to mitigate the adverse impacts of MDR-TB, restore health, and safeguard the long-term well-being of affected households.